Filing Details
- Accession Number:
- 0000899243-22-038993
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-19 16:54:16
- Reporting Period:
- 2022-12-15
- Accepted Time:
- 2022-12-19 16:54:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1698530 | Exicure Inc. | XCUR | Pharmaceutical Preparations (2834) | 815333008 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1930189 | Cbi Usa, Inc. | 3000 Western Avenue #400 Seattle WA 98121 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-12-15 | 3,400,000 | $1.60 | 4,218,299 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- On December 15, 2022, the stockholders of Exicure, Inc. approved the purchase by the Reporting Person of 3,400,000 shares of common stock at a price per share of $1.60 pursuant to the Securities Purchase Agreement, dated September 26, 2022. The purchase is expected to close promptly, but no later than January 20, 2023, subject to satisfaction or waiver of remaining conditions. Notwithstanding that the purchase has not closed yet, the Reporting Person may be deemed to beneficially own these shares due to satisfaction of the stockholder approval condition.
Billionaire Hedge Funds
